Screener
Aurinia Pharmaceuticals AUPH Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Net product sales | $79,412 | $66,574 | $152,975 | $126,545 |
| License, collaboration and royalty revenue | 3,808 | 3,434 | 7,950 | 5,928 |
| Total revenue | 83,220 | 70,008 | 160,925 | 132,473 |
| Operating expenses | ||||
| Cost of revenue | 6,555 | 7,115 | 13,060 | 15,689 |
| Selling, general and administrative | 23,508 | 26,018 | 45,537 | 46,357 |
| Research and development | 13,050 | 7,432 | 20,520 | 13,175 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's total revenue?
- Aurinia Pharmaceuticals (AUPH) reported total revenue of $83.22M in Q2 2026.
- How has Aurinia Pharmaceuticals's total revenue changed year-over-year?
- Aurinia Pharmaceuticals's total revenue increased by 18.9% year-over-year, from $70.01M to $83.22M.
- What is the long-term trend for Aurinia Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total revenue has grown at a 57.8% compound annual growth rate (CAGR), from $45.61M to $283.06M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Aurinia Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude